RSS  JOBS   SITE MAP 
 HOME 
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
 RESOURCE CENTER 
 SUBSCRIBE 
 SUBSCRIBE ASIA DIGEST 
  Friday, September 3, 2010 SEARCH     
 
 
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement



















 
Medical Technology  Products  Story
Abbott unveils integrated chemistry system

Singapore, July 31, 2008: American pharma company Abbott has previewed the ARCHITECT ci4100 Integrated System at the American Association of Clinical Chemistry (AACC) Annual Meeting. The ci4100 is an automated diagnostic analyzer that integrates immunoassay and clinical chemistry testing.
 
Expected to be available in the United States by mid-2009, subject to regulatory approvals, the ci4100 will expand Abbott's family of integrated systems, offering low-volume-testing laboratories and clinics increased productivity and performance.
 
As low-volume facilities continue to seek efficiency-enhancing solutions, the ci4100 is designed to deliver improved productivity by providing a large capacity of up to 85 onboard reagents and 180 samples that can be continuously loaded and unloaded during the testing process. The ci4100 also will effectively integrate clinical chemistry and immunoassay testing with an expansive test menu, while maintaining quick and consistent immediate turnaround times during both peak and off-peak hours. This helps low to mid-volume facilities meet the demands of increasing workloads and clinical requirements. The ci4100 can generate up to 800 clinical chemistry and 100 immunoassay tests per hour.
 
A prepared company release said, when available in the United States, the ci4100 will complete the ARCHITECT family of analyzers. The ARCHITECT system integrates two highly successful ARCHITECT instruments: the i1000SR immunoassay analyzer and the c4000 clinical chemistry system, which was developed with Abbott's partner, Toshiba. Because the ci4100 is based on Abbott's existing ARCHITECT ci8200 and ci16200-integrated platforms, it shares common hardware, software and reagents. Upon regulatory approval, Abbott will be the only company offering high, medium and low-volume integrated solutions leveraging the same software, reagents and sample carriers.

© BioSpectrum Bureau
  Email this articleComment on this article   Print this article
 
Advertisement





 
   
 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Jobs at CyberMedia | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[DQ Channels]  [The DQweek]  [DARE]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black